Olympics-Swimming-World records tumble as US rule the Paris pool
By Ian Ransom
PARIS, Aug 4 (Reuters) -Iron-man Bobby Finke and the U.S. women's medley relay team shattered world records in golden performances as the Olympic swim meet ended in exhilarating fashion on Sunday with the Americans on top again.
Floridian Finke took down Sun Yang's 12-year 1,500m world record as he retained the gold medal in the lung-busting event before the American women smashed their previous world mark for gold in the medley relay.
Combined, the golds saw the Americans finish with eight at the top of the swimming medal table, one more than second-placed Australia whose ambitions of ruling the Olympic pool for the first time since Melbourne 1956 were quashed.
It was by no means an American shut-out, though, with the U.S. men's medley relay team suffering their first defeat ever at Olympics meets dating back to the 1960 Rome Games in a febrile atmosphere at La Defense Arena.
China, anchored by the human missile Pan Zhanle, took the gold ahead of the U.S. team, whose talisman Caeleb Dressel took his first minor medal from a previously uniform set of nine golds.
"I feel like for a team USA, the expectation is gold," said Dressel who swam the third butterfly leg of the relay. "That's traditionally what we strive for and I don't think that changes any Olympic cycle.
"That was a close race, came down to the wire, and they had four great splits, we had four great splits, and they were faster, simple as that."
Sarah Sjostrom finished the Games on a huge high after claiming the women's 50m freestyle in 23.71 seconds, the evergreen Swede's two-gold haul surpassing all returns at her previous four Games.
"This was definitely my best (Olympics)," said the 30-year-old, who took the first of her three golds at Rio 2016.
"I'm definitely going to continue swimming for many years, but I mean, how can I top this ever?"
DOPING STORM STIRS AGAIN
Though the sport shone on the closing night, there was also a clear note of dissent over China's success amid a doping storm that engulfed the team in the leadup to Paris.
China, who finished fifth on the swimming medal table with two golds among their 12 medals, came to the Games under a cloud of suspicion after revelations in April that 23 of their swimmers tested positive for a banned heart medication but were allowed to compete at the Tokyo Games.
The World Anti-Doping Agency accepted a Chinese investigation's findings that the test results were due to contamination from a hotel kitchen the team were staying at.
The team China brought to Paris included a number of swimmers named among the 23 in media reports.
China was then thrust back into the doping spotlight last week when the New York Times reported that two of its swimmers in 2022 had tested positive for a banned steroid but had their provisional bans lifted when the results were blamed on contaminated food.
One of those two swimmers according to the Times report was competing at Paris.
WADA concluded there was no evidence to challenge the contaminated meat scenario.
Britain missed out on a podium place in the men's medley won by China, and triple Olympic champion Adam Peaty was pointed in his comments afterwards.
"One of my favourite quotes I've seen lately is 'There's no point in winning if you don't win it fair'," the breaststroker told reporters.
"I don't want to paint a whole nation or a whole group of people with one brush. I think it's very unfair.
"But there has been two cases and I think it's very disappointing."
Reuters Olympics coverage home https://www.reuters.com/sports/olympics/
Explainer: Olympics schedule, map, medals table, sports guides https://www.reuters.com/graphics/OLYMPICS-2024/EXPLAINER/byprqrwmqve/
Reporting by Ian Ransom; Additional reporting by Rohith Nair, Alan Baldwin and Steve Keating; Editing by Hugh Lawson
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
